nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Asenapine—Skin exfoliation—Prednisone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Asenapine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00413	0.00413	CcSEcCtD
Asenapine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Asenapine—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Asenapine—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Asenapine—Nausea—Auranofin—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Asenapine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Asenapine—Increased appetite—Betamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Asenapine—Increased appetite—Dexamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Asenapine—Dysarthria—Methotrexate—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Asenapine—Ulcer—Methotrexate—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Asenapine—Irritability—Methylprednisolone—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Asenapine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Asenapine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Asenapine—Inflammation—Methotrexate—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Asenapine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Asenapine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Asenapine—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Asenapine—Diabetes mellitus—Prednisone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Asenapine—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Asenapine—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Asenapine—Breast disorder—Methylprednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Asenapine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Asenapine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Asenapine—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Asenapine—Irritability—Dexamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Asenapine—Irritability—Betamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Asenapine—Weight increased—Prednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Asenapine—Increased appetite—Prednisone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Asenapine—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Asenapine—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Asenapine—Osteoarthritis—Prednisone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Asenapine—Weight increased—Triamcinolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Asenapine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Asenapine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Asenapine—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Asenapine—Irritability—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Asenapine—Weight increased—Betamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Asenapine—Weight increased—Dexamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Asenapine—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Asenapine—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Asenapine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Asenapine—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Asenapine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Asenapine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Asenapine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Asenapine—Neutropenia—Prednisone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Asenapine—Irritability—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Asenapine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Asenapine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Asenapine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Asenapine—Weight increased—Prednisone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Asenapine—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Asenapine—Depression—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Asenapine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Asenapine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Asenapine—Angioedema—Prednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Asenapine—Malaise—Prednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Asenapine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Asenapine—Syncope—Prednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Asenapine—Eye disorder—Betamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Asenapine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Asenapine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Asenapine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Asenapine—Angiopathy—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Asenapine—Convulsion—Prednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Asenapine—Hypertension—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Asenapine—Angioedema—Triamcinolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Asenapine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Asenapine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Asenapine—Malaise—Triamcinolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Asenapine—Malaise—Methylprednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Asenapine—Syncope—Triamcinolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Asenapine—Syncope—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Asenapine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Asenapine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Asenapine—Shock—Prednisolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Asenapine—Convulsion—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Asenapine—Tachycardia—Prednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Asenapine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Asenapine—Hypertension—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Asenapine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Asenapine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Asenapine—Eye disorder—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Asenapine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Asenapine—Depression—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Asenapine—Dry mouth—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Asenapine—Angioedema—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Asenapine—Angioedema—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Asenapine—Stomatitis—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Asenapine—Angiopathy—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Asenapine—Malaise—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Asenapine—Malaise—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Asenapine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Asenapine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Asenapine—Syncope—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Asenapine—Syncope—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Asenapine—Shock—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Asenapine—Insomnia—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Asenapine—Shock—Methylprednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Asenapine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Asenapine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Asenapine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Asenapine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Asenapine—Mental disorder—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Asenapine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Asenapine—Malnutrition—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Asenapine—Convulsion—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Asenapine—Convulsion—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Asenapine—Hypertension—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Asenapine—Hypertension—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Asenapine—Anxiety—Dexamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Asenapine—Anxiety—Betamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Asenapine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Asenapine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Asenapine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Asenapine—Insomnia—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Asenapine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Asenapine—Anaemia—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Asenapine—Shock—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Shock—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Agitation—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Asenapine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Asenapine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Asenapine—Tachycardia—Betamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Asenapine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Asenapine—Angioedema—Prednisone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Asenapine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Asenapine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Asenapine—Malaise—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Asenapine—Syncope—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Asenapine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Asenapine—Fatigue—Triamcinolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Asenapine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Asenapine—Hypotension—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Asenapine—Hypotension—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Asenapine—Angiopathy—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Asenapine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Asenapine—Convulsion—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Asenapine—Hypertension—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Asenapine—Arthralgia—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Asenapine—Anxiety—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Asenapine—Insomnia—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Asenapine—Insomnia—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Asenapine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Asenapine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Asenapine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Asenapine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Asenapine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Asenapine—Fatigue—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Asenapine—Fatigue—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Asenapine—Shock—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Asenapine—Tachycardia—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Asenapine—Anaemia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Asenapine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Asenapine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Asenapine—Malaise—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Asenapine—Dizziness—Prednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Asenapine—Asthenia—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Asenapine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Asenapine—Insomnia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Asenapine—Convulsion—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Asenapine—Rash—Prednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Asenapine—Dermatitis—Prednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Asenapine—Fatigue—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Asenapine—Headache—Prednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Asenapine—Constipation—Prednisone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Asenapine—Dizziness—Triamcinolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Asenapine—Dizziness—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Asenapine—Asthenia—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Asenapine—Asthenia—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Asenapine—Nausea—Prednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Asenapine—Vomiting—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Asenapine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Asenapine—Rash—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Asenapine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Asenapine—Rash—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Asenapine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Asenapine—Headache—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Asenapine—Headache—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Asenapine—Hypotension—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Asenapine—Dizziness—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Asenapine—Dizziness—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Asenapine—Insomnia—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Asenapine—Nausea—Triamcinolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Asenapine—Nausea—Methylprednisolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Asenapine—Somnolence—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Asenapine—Vomiting—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Asenapine—Vomiting—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Asenapine—Rash—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Rash—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Dermatitis—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Fatigue—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Headache—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Headache—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Asenapine—Asthenia—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Asenapine—Nausea—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Asenapine—Nausea—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Asenapine—Dizziness—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Asenapine—Vomiting—Prednisone—psoriatic arthritis	0.000986	0.000986	CcSEcCtD
Asenapine—Rash—Prednisone—psoriatic arthritis	0.000978	0.000978	CcSEcCtD
Asenapine—Dermatitis—Prednisone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Asenapine—Headache—Prednisone—psoriatic arthritis	0.000972	0.000972	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Asenapine—Asthenia—Methotrexate—psoriatic arthritis	0.00093	0.00093	CcSEcCtD
Asenapine—Nausea—Prednisone—psoriatic arthritis	0.000921	0.000921	CcSEcCtD
Asenapine—Dizziness—Methotrexate—psoriatic arthritis	0.000857	0.000857	CcSEcCtD
Asenapine—Vomiting—Methotrexate—psoriatic arthritis	0.000824	0.000824	CcSEcCtD
Asenapine—Rash—Methotrexate—psoriatic arthritis	0.000817	0.000817	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—psoriatic arthritis	0.000817	0.000817	CcSEcCtD
Asenapine—Headache—Methotrexate—psoriatic arthritis	0.000812	0.000812	CcSEcCtD
Asenapine—Nausea—Methotrexate—psoriatic arthritis	0.00077	0.00077	CcSEcCtD
